Oventus
OVN.AXOventus Medical Limited Price (OVN.AX)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
161,921,514
(23.9676)%Income Statement Summary
| Revenue | |
| Cost of Revenue | |
| Gross Profit | |
| Operating Expenses | |
| Operating Income | |
| Other Expenses | |
| Net Income |
Income Statement
Oventus Medical LimitedCurrency: AUD
| YEAR | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||
| Revenue |
0.00
+0% |
447,994.00
+0% |
271,322.00
-39% |
331,837.00
+22% |
419,298.00
+26% |
1,089,535.00
+160% |
|||||||||||||
| Cost of Revenue | |||||||||||||||||||
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 231,736.00 | 687,912.00 | |||||||||||||
| Gross Profit | |||||||||||||||||||
| Gross Profit |
0.00
+0% |
447,994.00
+0% |
271,322.00
-39% |
331,837.00
+22% |
187,562.00
-43% |
401,623.00
+114% |
|||||||||||||
| Gross Profit Ratio | (0.00%) | (1.00%) | (1.00%) | (1.00%) | (0.45%) | (0.37%) | |||||||||||||
| Operating Expenses | |||||||||||||||||||
| Research and Development | 0.00 | 239,977.00 | 269,057.00 | 389,202.00 | 571,831.00 | 186,100.00 | |||||||||||||
| General and Administrative | 0.00 | 3,075,047.00 | 3,477,837.00 | 4,750,109.00 | 5,799,541.00 | 6,803,964.00 | |||||||||||||
| Selling, General & Admin... | 0.00 | 3,927,466.00 | 3,884,082.00 | 5,421,035.00 | 6,320,240.00 | 7,269,336.00 | |||||||||||||
| Selling & Marketing Exp... | 0.00 | 852,419.00 | 406,245.00 | 670,926.00 | 520,699.00 | 465,372.00 | |||||||||||||
| Depreciation and Amortiz... | 0.00 | 615,621.00 | 757,636.00 | 768,453.00 | 1,526,652.00 | 1,327,835.00 | |||||||||||||
| Other Expenses | 0.00 | 2,930,539.00 | 2,270,903.00 | 2,676,568.00 | 3,533,145.00 | 2,903,575.00 | |||||||||||||
| Total Operating Expenses | 0.00 | 7,097,982.00 | 6,424,042.00 | 8,486,805.00 | 10,425,216.00 | 10,359,011.00 | |||||||||||||
| Cost and Exponses | 0.00 | 7,097,982.00 | 6,424,042.00 | 8,486,805.00 | 10,656,952.00 | 11,046,923.00 | |||||||||||||
| Operating Income | |||||||||||||||||||
| Operating Income |
0.00
+0% |
-6,649,988.00
+0% |
-6,152,720.00
-7% |
-8,154,968.00
+33% |
-10,120,994.00
+24% |
-9,800,870.00
-3% |
|||||||||||||
| Operating Income Ratio | (0.00%) | (-14.84%) | (-22.68%) | (-24.58%) | (-24.14%) | (-9.00%) | |||||||||||||
| Other Income and Exp... | |||||||||||||||||||
| Interest Income | 0.00 | 88,661.00 | 191,157.00 | 154,539.00 | 45,003.00 | 31,455.00 | |||||||||||||
| Interest Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 5,370.00 | 30,692.00 | |||||||||||||
| Total Other Income/Exp... | 0.00 | 139,874.00 | 282,173.00 | 306,713.00 | -5,370.00 | -30,692.00 | |||||||||||||
| EBITDA | |||||||||||||||||||
| EBITDA | 0.00 | -5,894,493.00 | -5,112,911.00 | -7,386,515.00 | -8,594,342.00 | -8,473,035.00 | |||||||||||||
| EBITDA ratio | (0.00%) | (-13.16%) | (-18.84%) | (-22.26%) | (-20.50%) | (-7.78%) | |||||||||||||
| Income Before Tax | |||||||||||||||||||
| Income Before Tax | 0.00 | -6,510,114.00 | -5,870,547.00 | -7,848,255.00 | -10,126,364.00 | -9,831,562.00 | |||||||||||||
| Income Before Tax Ratio | (0.00%) | (-14.53%) | (-21.64%) | (-23.65%) | (-24.15%) | (-9.02%) | |||||||||||||
| Income Tax Expense | |||||||||||||||||||
| Income Tax Expense | 0.00 | 139,874.00 | 282,173.00 | -306,713.00 | 77,027.00 | 155,755.00 | |||||||||||||
| Net Income | |||||||||||||||||||
| Net Income | 0.00
+0% |
-6,510,114.00
+0% |
-5,870,547.00
-10% |
-7,541,542.00
+28% |
-10,203,391.00
+35% |
-9,987,317.00
-2% |
|||||||||||||
| Net Income Ratio | (0.00%) | (-14.53%) | (-21.64%) | (-22.73%) | (-24.33%) | (-9.17%) | |||||||||||||
| Earning Per Share | |||||||||||||||||||
| Basic EPS | 0.00 | -0.09 | -0.06 | -0.07 | -0.08 | -0.06 | |||||||||||||
| Diluted EPS | 0.00 | -0.09 | -0.06 | -0.07 | -0.08 | -0.06 | |||||||||||||
| Share Outstanding | |||||||||||||||||||
| Basic Share Outstanding | 32,938,975.00 | 71,811,203.00 | 100,379,121.00 | 107,278,283.00 | 130,615,992.00 | 161,921,514.00 | |||||||||||||
| Diluted Share Outstanding | 32,938,975.00 | 71,811,203.00 | 100,379,121.00 | 107,278,283.00 | 130,615,992.00 | 161,921,514.00 | |||||||||||||